Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 4 Cash-Heavy Large Cap Biotech Stocks That Analysts Rate As Buy
4 Cash-Heavy Large Cap Biotech Stocks That Analysts Rate As Buy
4 Cash-Heavy Large Cap Biotech Stocks That Analysts Rate As Buy
Submitted by
admin
on August 18, 2012 - 3:34pm
Source:
Seeking Alpha
News Tags:
Amgen
Celgene
Alexion
Regeneron
Headline:
4 Cash-Heavy Large Cap Biotech Stocks That Analysts Rate As Buy
Do Not Allow Advertisers to Use My Personal information
